A more targeted therapy to treat inflammatory bowel disease
UC Riverside mouse study focuses on the receptor TNFR1
New hope for people living with a genetic cause of autism
UC Riverside research shows gene reactivation can be used to treat Fragile X syndrome
Study links high cholesterol, cardiovascular disease to plastics
UC Riverside-led mouse study finds a receptor greatly contributes to the harmful effects of plastic-associated chemicals
How sepsis need not be fatal
UC Riverside-led team identifies molecular driver and protector of this life-threatening medical emergency
Public lecture to focus on synthetic genome engineering
Lei Stanley Qi of Stanford University will give the 2021 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside
Novel mechanism links genetic defect in IBD patients to gut leakiness
UC Riverside-led study in mice and human tissue is the first to show how a disease mutation weakens barrier properties of epithelial cells lining the gut
How concerned should we be about the Delta variant?
UC Riverside experts share their thoughts
Salton Sea aerosol exposure triggers unique and mysterious pulmonary response
UC Riverside mouse study suggests inflammation could play key role in progression to asthma
How the South African COVID-19 variant was found
UC Riverside biomedical scientists were part of an international team that identified the coronavirus strain
What UC Riverside scientists have to say about vaccines, variants, and antibodies
Immunity generated by vaccination is better than immunity from an actual infection, says an expert
Remyelinating drug could improve vision in patients with multiple sclerosis
UC Riverside-led mouse study stresses MS treatment should be started early
Biomedical scientist explains how Covid-19 vaccines work
Dr. David Lo at the UC Riverside School of Medicine is an expert on vaccines
Observed COVID-19 variability may have underlying molecular sources
UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity
Drug found to correct gene defect that causes immune-driven gut leakiness
UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells